|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
186.300 +8.300 (+4.663%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 59,559 | (270,847) | (485,942) |
| Net Cash from / (used in) Investing Activities | -- | (1,025,417) | (32,150) | (94,384) |
| Net Cash from / (used in) Financing Activities | -- | 2,382,281 | 313,452 | 647,316 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,416,423 | 10,455 | 66,990 |
| Cash & Cash Equivalents at beginning of period | -- | 92,960 | 81,793 | 16,189 |
| Effect of Foreign Exchange Rate Changes | -- | 19,391 | 712 | (1,386) |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,528,774 | 92,960 | 81,793 |
| Remarks: | Real time quote last updated: 27/11/2024 10:13 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 310,226 |
| %Change | -- |
| EPS / (LPS) | RMB 1.410 |
| NBV Per Share (¥) | RMB 14.401 |